Bio-Rad Laboratories (BIO) Research & Development (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Research & Development data on file, last reported at $62.9 million in Q1 2026.

• On a quarterly basis, Research & Development fell 14.42% year-over-year to $62.9 million in Q1 2026; TTM through Mar 2026 was $265.0 million, a 12.54% decrease from a year earlier, with the FY2025 full-year figure at $275.6 million, down 6.86% from the prior year.
• Research & Development for Q1 2026 stood at $62.9 million, down from $70.3 million in the prior quarter.
• Over the last five years, Research & Development for BIO reached as high as $91.0 million in Q3 2024 and fell as low as $43.5 million in Q3 2023.
• Historically, Research & Development has averaged $67.0 million across 5 years, with a median of $66.2 million in 2022.
• Across the five-year window, Research & Development sank 34.84% in 2023 and jumped 109.03% in 2024, its largest moves.
• Year by year, Research & Development stood at $66.2 million in 2022, then dropped by 3.53% to $63.9 million in 2023, then grew by 24.62% to $79.6 million in 2024, then decreased by 11.68% to $70.3 million in 2025, then declined by 10.53% to $62.9 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $62.9 million in Q1 2026, $70.3 million in Q4 2025, and $71.3 million in Q3 2025.